Literature DB >> 24011138

Improving the endoscopic endonasal transclival approach: the importance of a precise layer by layer reconstruction.

Maurizio Iacoangeli1, Alessandro Di Rienzo, Lucia Giovanna Maria di Somma, Elisa Moriconi, Lorenzo Alvaro, Massimo Re, Fabrizio Salvinelli, Massimiliano Carassiti, Massimo Scerrati.   

Abstract

BACKGROUND. The endoscopic endonasal transclival approach (EETCA) is a minimally-invasive technique allowing a direct route to the base of implant of clival lesions with reduced brain and neurovascular manipulation. On the other hand, it is associated with potentially severe complications related to the difficulties in reconstructing large skull base defects with a high risk of postoperative cerebrospinal fluid (CSF) leakage. The aim of this paper is to describe a precise layer by layer reconstruction in the EETCA including the suture of the mucosa as an additional reinforcing layer between cranial and nasal cavity in order to speed up the healing process and reduce the incidence of CSF leak. METHODS. This closure technique was applied to the last six cases of EETCA used for clival meningiomas (2), clival chordomas (2), clival metastasis (1), and craniopharyngioma with clival extension (1). RESULTS. After a mean follow-up of 6 months we had no one case of postoperative CSF leakage or infections. Seriated outpatient endoscopic endonasal controls showed a fast healing process of nasopharyngeal mucosa with less patient discomfort. CONCLUSIONS. Our preliminary experience confirms the importance of a precise reconstruction of all anatomical layers violated during the surgical approach, including the nasopharygeal mucosa.

Entities:  

Mesh:

Year:  2013        PMID: 24011138     DOI: 10.3109/02688697.2013.835375

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  6 in total

1.  Subtemporal Retrolabyrinthine (Posterior Petrosal) versus Endoscopic Endonasal Approach to the Petroclival Region: An Anatomical and Computed Tomography Study.

Authors:  Eric Mason; Jason Van Rompaey; C Arturo Solares; Ramon Figueroa; Daniel Prevedello
Journal:  J Neurol Surg B Skull Base       Date:  2015-10-29

Review 2.  Transclival approaches for intradural pathologies: historical overview and present scenario.

Authors:  Francesco Belotti; Francesco Tengattini; Davide Mattavelli; Marco Ferrari; Antonio Fiorentino; Silvia Agnelli; Alberto Schreiber; Piero Nicolai; Marco Maria Fontanella; Francesco Doglietto
Journal:  Neurosurg Rev       Date:  2020-02-14       Impact factor: 3.042

3.  Endoscopic endonasal approach to the craniocervical junction: the importance of anterior C1 arch preservation or its reconstruction.

Authors:  M Re; M Iacoangeli; L Di Somma; L Alvaro; D Nasi; G Magliulo; F M Gioacchini; D Fradeani; M Scerrati
Journal:  Acta Otorhinolaryngol Ital       Date:  2016-04-29       Impact factor: 2.124

4.  Minimally Invasive Supraorbital Key-hole Approach for the Treatment of Anterior Cranial Fossa Meningiomas.

Authors:  Maurizio Iacoangeli; Niccolò Nocchi; Davide Nasi; Alessandro DI Rienzo; Mauro Dobran; Maurizio Gladi; Roberto Colasanti; Lorenzo Alvaro; Gabriele Polonara; Massimo Scerrati
Journal:  Neurol Med Chir (Tokyo)       Date:  2016-01-25       Impact factor: 1.742

5.  Combined supra-transorbital keyhole approach for treatment of delayed intraorbital encephalocele: A minimally invasive approach for an unusual complication of decompressive craniectomy.

Authors:  Lucia di Somma; Maurizio Iacoangeli; Davide Nasi; Paolo Balercia; Ettore Lupi; Riccardo Girotto; Gabriele Polonara; Massimo Scerrati
Journal:  Surg Neurol Int       Date:  2016-01-07

6.  Skull base repair following endonasal pituitary and skull base tumour resection: a systematic review.

Authors:  Danyal Z Khan; Ahmad M S Ali; Chan Hee Koh; Neil L Dorward; Joan Grieve; Hugo Layard Horsfall; William Muirhead; Thomas Santarius; Wouter R Van Furth; Amir H Zamanipoor Najafabadi; Hani J Marcus
Journal:  Pituitary       Date:  2021-05-10       Impact factor: 4.107

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.